Related references
Note: Only part of the references are listed.Radium-223 for metastatic, castration- resistant prostate cancer: A retrospective chart review study of real-world use in a tertiary hospital in Taiwan
Wei -Chun Weng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)
Neurophysiological mechanisms of cancer-induced bone pain
Xuan-Qi Zheng et al.
JOURNAL OF ADVANCED RESEARCH (2022)
Patients' Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study
Marco Mazzotta et al.
CANCER MANAGEMENT AND RESEARCH (2022)
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study
Andreas Jakob et al.
JOURNAL OF BONE ONCOLOGY (2022)
Manifestations of Opioid Stigma in Patients With Advanced Cancer: Perspectives From Patients and Their Support Providers
Hailey W. Bulls et al.
JCO ONCOLOGY PRACTICE (2022)
Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223
Sushil K. Badrising et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2022)
A randomised trial of 4-versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
Mark Clemons et al.
EUROPEAN JOURNAL OF CANCER (2021)
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center
Rana R. McKay et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2021)
The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costs
Jacopo Giuliani et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2021)
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study
Neeraj Agarwal et al.
JOURNAL OF UROLOGY (2021)
A Neuroskeletal Atlas: Spatial Mapping and Contextualization of Axon Subtypes Innervating the Long Bones of C3H and B6 Mice
Madelyn R. Lorenz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain
Sebastiano Mercadante et al.
CANCERS (2021)
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer
Deaglan McHugh et al.
CLINICAL GENITOURINARY CANCER (2021)
Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer
Stacey A. Kenfield et al.
CANCER MEDICINE (2021)
Can Naloxegol Therapy Improve Quality of Life in Patients with Advanced Cancer?
Rita Ostan et al.
CANCERS (2021)
Sensory nerves: A driver of the vicious cycle in bone metastasis?
Toshiyuki Yoneda et al.
JOURNAL OF BONE ONCOLOGY (2021)
Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study
H. Palmedo et al.
ANNALS OF ONCOLOGY (2021)
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Reciprocal interactions between osteoclasts and nociceptive sensory neurons in bone cancer pain
Amanda S. Andriessen et al.
PAIN REPORTS (2021)
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer
C. N. Sternberg et al.
ANNALS OF ONCOLOGY (2020)
A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naive Metastatic Prostate Cancer
Paul G. Corn et al.
CLINICAL CANCER RESEARCH (2020)
A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population
Sushil K. Badrising et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain
Sebastiano Mercadante et al.
ONCOLOGIST (2020)
Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes A Meta-analysis of Individual Patient Data From Randomized Clinical Trials
Safae Terrisse et al.
JAMA ONCOLOGY (2020)
Central Neuropathic Mechanisms in Pain Signaling Pathways: Current Evidence and Recommendations
Omar Viswanath et al.
ADVANCES IN THERAPY (2020)
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer
Neal D. Shore et al.
CLINICAL GENITOURINARY CANCER (2020)
Radium-223 as an Approved Modality for Treatment of Bone Metastases
Ana Emilia Brito et al.
SEMINARS IN NUCLEAR MEDICINE (2020)
Bone health in cancer: ESMO Clinical Practice Guidelines
R. Coleman et al.
ANNALS OF ONCOLOGY (2020)
Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: A randomized controlled trial
Srinivas R. Banala et al.
PLOS ONE (2020)
Peripheral Neuropathic Pain: From Experimental Models to Potential Therapeutic Targets in Dorsal Root Ganglion Neurons
Ti-Yen Yeh et al.
CELLS (2020)
Prospective administration of anti-nerve growth factor treatment effectively suppresses functional connectivity alterations after cancer-induced bone pain in mice
David Buehlmann et al.
PAIN (2019)
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
Matthew Smith et al.
LANCET ONCOLOGY (2019)
The role of rapid onset fentanyl products in the management of breakthrough pain in cancer patients
Joanna Brzakala et al.
PHARMACOLOGICAL REPORTS (2019)
Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives
Jennifer K. Logan et al.
JOURNAL OF ONCOLOGY PRACTICE (2019)
Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer Practical Management Issues for Patient Selection
Robert B. Den et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)
Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer
Yongmei Shen et al.
CELL COMMUNICATION AND SIGNALING (2019)
Nerves in Bone: Evolving Concepts in Pain and Anabolism
Jennifer M. Brazill et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
Ronald de Wit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Bone Pain in Cancer Patients: Mechanisms and Current Treatment
Renata Zajaczkowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
Ethan M. Basch et al.
EUROPEAN UROLOGY (2019)
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
Thorsten D. Poeppel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis
Robert Janknegt et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2018)
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
M. Fallon et al.
ANNALS OF ONCOLOGY (2018)
Tumor necrosis factor- induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation
Aerken Maolake et al.
CANCER SCIENCE (2018)
EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
Daria Handkiewicz-Junak et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Cellular and Molecular Mediators of Bone Metastatic Lesions
Giulia Battafarano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases
Daniel A. Galvao et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2018)
Update of the systematic review of palliative radiation therapy fractionation for bone metastases
Shayna E. Rich et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis
Sun H. Park et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Focused ultrasound for the treatment of bone metastases: effectiveness and feasibility
Anne-Sophie Bertrand et al.
JOURNAL OF THERAPEUTIC ULTRASOUND (2018)
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)
Sebastiano Mercadante et al.
ADVANCES IN THERAPY (2017)
A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial
Joyce M. van Dodewaard-de Jong et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Tomasz M. Beer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA
Stephane Oudard et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Mediation of Movement-Induced Breakthrough Cancer Pain by IB4-Binding Nociceptors in Rats
Joshua Havelin et al.
JOURNAL OF NEUROSCIENCE (2017)
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models
Mari I. Suominen et al.
CLINICAL CANCER RESEARCH (2017)
De-escalation of bone-targeted agents for metastatic prostate cancer
Brian Younho Hong et al.
CURRENT ONCOLOGY (2016)
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
Roger von Moos et al.
SUPPORTIVE CARE IN CANCER (2016)
Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group
Sebastiano Mercadante et al.
SUPPORTIVE CARE IN CANCER (2016)
Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study
S. Nilsson et al.
ANNALS OF ONCOLOGY (2016)
Cyclin A1 and P450 Aromatase Promote Metastatic Homing and Growth of Stem-like Prostate Cancer Cells in the Bone Marrow
Regina Miftakhova et al.
CANCER RESEARCH (2016)
Skeletal complications in cancer patients with bone metastases
Shunsuke Tsuzuki et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
Breakthrough cancer pain: twenty-five years of study
Sebastiano Mercadante et al.
PAIN (2016)
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both The TRAPEZE Randomized Clinical Trial
Nicholas D. James et al.
JAMA ONCOLOGY (2016)
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
C. Parker et al.
ANNALS OF ONCOLOGY (2015)
Radium-223 Dichloride: A Novel Treatment Option for Castration-Resistant Prostate Cancer Patients With Symptomatic Bone Metastases
Shane McGann et al.
ANNALS OF PHARMACOTHERAPY (2015)
Management of bone metastases in prostate cancer: a review
Marc Bienz et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2015)
New insights of nociceptor sensitization in bone cancer pain
Baojin Hua et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Acidic microenvironment and bone pain in cancer-colonized bone
Toshiyuki Yoneda et al.
BONEKEY REPORTS (2015)
Radium Ra 223 Dichloride Injection: US Food and Drug Administration Drug Approval Summary
Paul G. Kluetz et al.
CLINICAL CANCER RESEARCH (2014)
RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
Gina Chia-Yi Chu et al.
ENDOCRINE-RELATED CANCER (2014)
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial
Peter Hoskin et al.
LANCET ONCOLOGY (2014)
Bone cancer pain: from mechanism to therapy
Patrick W. Mantyh
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2014)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
Bone cancer pain: Causes, consequences, and therapeutic opportunities
Patrick Mantyh
PAIN (2013)
Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments
Arjun Muralidharan et al.
INFLAMMOPHARMACOLOGY (2013)
The role of the bone microenvironment in skeletal metastasis
Yu Zheng et al.
JOURNAL OF BONE ONCOLOGY (2013)
Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint
Joseph R. Ghilardi et al.
ARTHRITIS AND RHEUMATISM (2012)
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
K. Fizazi et al.
EUROPEAN JOURNAL OF CANCER (2012)
Disorders of Bone Remodeling
Xu Feng et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
New targets, new drugs for metastatic bone pain: a new philosophy
Francesco Pantano et al.
EXPERT OPINION ON EMERGING DRUGS (2011)
Breast Cancer-Induced Bone Remodeling, Skeletal Pain, and Sprouting of Sensory Nerve Fibers
Aaron P. Bloom et al.
JOURNAL OF PAIN (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
BLOCKADE OF NERVE SPROUTING AND NEUROMA FORMATION MARKEDLY ATTENUATES THE DEVELOPMENT OF LATE STAGE CANCER PAIN
W. G. Mantyh et al.
NEUROSCIENCE (2010)
Pain predicts overall survival in men with metastatic castration-refractory prostate cancer
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Expression and activation of alpha(V)beta(3) integrins by SDF-I/CXCI2 increases the aggressiveness of prostate cancer cells
Yan-Xi Sun et al.
PROSTATE (2007)
In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance
S Bredenberg et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
Share Paper
